Madeleine Roach to Become Country President of Sanofi in Germany
The new position of Country President is Sanofi's response to the current situation in Germany
Advertisement
Sanofi in Germany is strengthening its leadership structure: Madeleine Roach will assume the newly created position of Country President effective September 1, 2026. She will also be responsible for the tri-national organization comprising Germany, Austria, and Switzerland. The Supervisory Board has now appointed her to her new role as Managing Director.
With the new position of Country President, Sanofi in Germany is responding to the complex situation the country currently faces: on the one hand, the U.S. administration’s Most-Favored-Nation policy and its implications for the future supply of innovative treatments to patients in Germany. On the other hand, there is the current health policy situation resulting from the Statutory Health Insurance Contribution Rate Stabilization Act and its implications for the pharmaceutical industry. Going forward, Roach will coordinate Sanofi’s activities in Germany and represent the company externally. This new position underscores Germany’s importance as one of the Group’s top three countries.
Manuela Buxo, Group Executive Vice President of the Global Business Unit Speciality Care: “By appointing Madeleine Roach to the new role of ‘Country President,’ Sanofi is underscoring Germany’s importance within the corporate group. After all, Germany is our most important market after the U.S. and China. I am very pleased that Madeleine will bring her executive board experience to bear in shaping this newly created position to strengthen our presence in Germany. This is particularly important in light of the political challenges we face. Madeleine will report to me in her new role.”
Brendan O’Callaghan, Group Executive Vice President of Manufacturing & Supply and Chairman of the Supervisory Board of Sanofi in Germany: “The Supervisory Board is pleased to have recruited Madeleine Roach, such an experienced leader, to join the Executive Board and assume the newly created position of Country President. She brings extensive international experience in business operations, digitalization, and the transformation of business processes—exactly the expertise we need in Germany at this time.”
Madeleine Roach joined Sanofi in 2022 as Head of Internal Audit and Risk Management and assumed the newly created role of Executive Vice President of Business Operations on the global Executive Board in October 2023. In this role, she was responsible for company-wide service functions across the value chain with the goal of increasing efficiency and productivity within the Group. Previously, Roach held various leadership positions at AstraZeneca, most recently as Head of Global Finance Services APAC in Malaysia. There, she successfully established shared-service structures, drove digitalization initiatives, and positioned the location as an attractive employer for top talent. After initially joining AstraZeneca Germany, she remained connected to the market for many years as a member and chair of the Supervisory Board. Roach began her career at PwC and KPMG in Germany and the United Kingdom in the areas of assurance and advisory. A native of Germany, she is the mother of one son and holds a Bachelor of Arts (Honors) in Economics and Politics from the University of London’s School of Oriental and African Studies.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Other news from the department people
